Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy
HCV GT 3-infected patients remain at a higher risk of OLDP even after achieving SVR by DAAs, especially patients with advanced liver fibrosis and at high risk for reinfection or virological late relapse.
Authors
- Dachuan Cai (ORCID: https://orcid.org/0000-0003-3269-8549)
- Ni Wang (ORCID: https://orcid.org/0009-0002-1277-4575)
- Xiping Ran
- Ying Wang (ORCID: https://orcid.org/0000-0002-8015-3546)
- Gong Chen (ORCID: https://orcid.org/0000-0002-1857-3670)
- Xu Yang (ORCID: https://orcid.org/0000-0002-5752-7255)
- Cheng Zeng (ORCID: https://orcid.org/0000-0002-2027-5090)
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-02-03
- DOI
- https://doi.org/10.3389/fcimb.2025.1510939
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 2.64